Conformation-Dependent Interactions Between HIV-1 Envelope Glycoproteins and Broadly Neutralizing Antibodies

被引:0
|
作者
Flemming, Juliana [1 ]
Wiesen, Lisa [1 ]
Herschhorn, Alon [1 ]
机构
[1] Univ Minnesota, Dept Med, Div Infect Dis & Int Med, Room 2-101 MRF,689 23rd Ave SE, Minneapolis, MN 55455 USA
关键词
HIV-1; entry; HIV-1 envelope glycoproteins; conformational transitions; broadly neutralizing antibodies; HUMAN-IMMUNODEFICIENCY-VIRUS; PROXIMAL EXTERNAL-REGION; HUMAN MONOCLONAL-ANTIBODIES; GP120 INNER DOMAIN; CD4; BINDING-SITE; CD4-BOUND CONFORMATION; POTENT NEUTRALIZATION; GP41-GP120; INTERFACE; STRUCTURAL BASIS; TYPE-1; ENVELOPE;
D O I
10.1089/aid.2018.0102
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HIV type 1 (HIV-1) envelope glycoproteins (Env) mediate virus entry and are the target of neutralizing antibodies. Binding of the metastable HIV-1 Env trimer to the CD4 receptor triggers structural rearrangements that mediate Env conformational transitions from a closed conformation to a more open state through an intermediate step. Recent studies have revealed new insights on the dynamics, regulation, and molecular mechanisms of Env transitions along the entry pathway. In this study, we provide an overview of the current knowledge on Env conformational dynamics and the relationship between Env conformational states and neutralization selectivity of the broadly neutralizing antibodies that develop in 10%-20% of infected individuals and may provide guidance for the development of an effective HIV-1 vaccine.
引用
收藏
页码:794 / 803
页数:10
相关论文
共 50 条
  • [1] Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
    Gnanakaran, S.
    Daniels, Marcus G.
    Bhattacharya, Tanmoy
    Lapedes, Alan S.
    Sethi, Anurag
    Li, Ming
    Tang, Haili
    Greene, Kelli
    Gao, Hongmei
    Haynes, Barton F.
    Cohen, Myron S.
    Shaw, George M.
    Seaman, Michael S.
    Kumar, Amit
    Gao, Feng
    Montefiori, David C.
    Korber, Bette
    PLOS COMPUTATIONAL BIOLOGY, 2010, 6 (10)
  • [2] HIV-1 envelope glycoprotein immunogens to induce broadly neutralizing antibodies
    Sliepen, Kwinten
    Sanders, Rogier W.
    EXPERT REVIEW OF VACCINES, 2016, 15 (03) : 349 - 365
  • [3] Characteristics of Envelope Genes in a Chinese Chronically HIV-1 Infected Patient With Broadly Neutralizing Activity
    Zhang, Dai
    Zou, Sen
    Hu, Yuanyuan
    Hou, Jiali
    Hu, Xintao
    Ren, Li
    Ma, Liying
    He, Xiang
    Shao, Yiming
    Hong, Kunxue
    FRONTIERS IN MICROBIOLOGY, 2019, 10
  • [4] Conformational flexibility of HIV-1 envelope glycoproteins modulates transmitted/founder sensitivity to broadly neutralizing antibodies
    Parthasarathy, Durgadevi
    Pothula, Karunakar Reddy
    Ratnapriya, Sneha
    Cervera Benet, Hector
    Parsons, Ruth
    Huang, Xiao
    Sammour, Salam
    Janowska, Katarzyna
    Harris, Miranda
    Sodroski, Joseph
    Acharya, Priyamvada
    Herschhorn, Alon
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [5] Broadly Neutralizing Antibodies and their Significance for HIV-1 Vaccines
    Gonzalez, Nuria
    Alvarez, Amparo
    Alcami, Jose
    CURRENT HIV RESEARCH, 2010, 8 (08) : 602 - 612
  • [6] Broadly Neutralizing Antibodies for HIV-1 Prevention
    Walsh, Stephen R.
    Seaman, Michael S.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [7] Broadly neutralizing antibodies against HIV-1: Templates for a vaccine
    van Gils, Marit J.
    Sanders, Rogier W.
    VIROLOGY, 2013, 435 (01) : 46 - 56
  • [8] Antigenic landscape of the HIV-1 envelope and new immunological concepts defined by HIV-1 broadly neutralizing antibodies
    Wu, Xueling
    Kong, Xiang-Peng
    CURRENT OPINION IN IMMUNOLOGY, 2016, 42 : 56 - 64
  • [9] Broadly Neutralizing Antibodies against HIV-1 As a Novel Aspect of the Immune Response
    Shcherbakov, D. N.
    Bakulina, A. Y.
    Karpenko, L. I.
    Ilyichev, A. A.
    ACTA NATURAE, 2015, 7 (04): : 11 - 21
  • [10] Use of broadly neutralizing antibodies for HIV-1 prevention
    Pegu, Amarendra
    Hessell, Ann J.
    Mascola, John R.
    Haigwood, Nancy L.
    IMMUNOLOGICAL REVIEWS, 2017, 275 (01) : 296 - 312